ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Interventional Cardiology

Top Interventional Cardiology Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM HILL M.D.

Interventional Cardiology

12,532

$515K

994
819 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $53

HERCULES PANAYIOTOU M.D.

Interventional Cardiology

9,482

$613K

594
494 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $53

THOMAS WOOL MD

Interventional Cardiology

8,641

$575K

807
643 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $53

ALVARO ALDANA MD

Interventional Cardiology

8,455

$349K

628
474 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $53

GEORGE HEMSTREET MD

Interventional Cardiology

8,153

$861K

647
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 24%

$106
Average prescription price

Avg: $53

M. AHMED M.D.

Interventional Cardiology

6,992

$336K

581
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $53

CHAD ALFORD MD

Interventional Cardiology

6,935

$261K

573
470 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $53

WILLIAM MACLEAN M.D.

Interventional Cardiology

6,916

$229K

455
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$33
Average prescription price

Avg: $53

SANJEEV SAXENA MD

Interventional Cardiology

6,572

$361K

366
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $53

BRIAN COLE M.D.

Interventional Cardiology

6,181

$329K

444
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $53

JOAQUIN ARCINIEGAS MD

Interventional Cardiology

5,720

$382K

482
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $53

LOVDIE LEWIS MD

Interventional Cardiology

5,505

$276K

443
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $53

HASAN GUVEN MD

Interventional Cardiology

5,504

$233K

378
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $53

JEFFREY ANDERSON MD

Interventional Cardiology

5,392

$240K

493
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $53

PERVAIZ MALIK

Interventional Cardiology

5,165

$249K

436
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $53

JOHN LEDOUX M.D.

Interventional Cardiology

5,122

$181K

533
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $53

PAUL MOORE M.D.

Interventional Cardiology

3,199

$198K

380
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $53

JAMES DOBBS M.D.

Interventional Cardiology

3,194

$158K

245
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $53

JOHN GALLA MD

Interventional Cardiology

3,071

$115K

370
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $53

ARTHUR GRANT MD

Interventional Cardiology

3,046

$118K

367
294 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $53

CHRISTOPHER KING M.D.

Interventional Cardiology

2,800

$105K

260
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $53

KELLEY SMITH M. D.

Interventional Cardiology

2,782

$214K

302
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $53

WARREN HARDY MD

Interventional Cardiology

2,675

$75.8K

323
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$28
Average prescription price

Avg: $53

RICHARD CRUM M.D.

Interventional Cardiology

2,600

$225K

319
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 24%

$87
Average prescription price

Avg: $53

CRAIG PETERSON M.D.

Interventional Cardiology

2,595

$98.7K

323
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank